Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
Andrew M. Yeager(University of Arizona), John R. Wingard(University of Florida Health), Rein Saral(Johns Hopkins University), Robert K. Stuart(Memorial Sloan Kettering Cancer Center), Judith E. Karp(Emory University), Donald J. Fuller(Johns Hopkins University), Scott D. Rowley(Johns Hopkins Hospital), Richard F. Ambinder(Johns Hopkins University), Herbert Kaizer, O. Michael Colvin(Dartmouth College), Lyle L. Sensenbrenner(Johns Hopkins University), Philip J. Burke(Johns Hopkins University), George W. Santos(Johns Hopkins University), Georgia B. Vogelsang(Johns Hopkins University), Janice M. Davis(Johns Hopkins University), Hayden G. Braine(Johns Hopkins University), W. Stratford May(City of Cape Town), William H. Burns
Cited by 441
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k